We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
-$216M
Cap. Flow
-$62.5M
Cap. Flow %
-1.18%
Top 10 Hldgs %
23.94%
Holding
294
New
29
Increased
89
Reduced
98
Closed
32

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$46.6M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
BCR
CR Bard Inc.
BCR
+$31.1M
4
CVS icon
CVS Health
CVS
+$27.8M
5
DHR icon
Danaher
DHR
+$26.6M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$36.5M
2
PNC icon
PNC Financial Services
PNC
+$34.3M
3
CELG
Celgene Corp
CELG
+$32.4M
4
AGN
Allergan plc
AGN
+$28M
5
CNC icon
Centene
CNC
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 23.21%
3 Financials 21.91%
4 Communication Services 9.94%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CB
276
DELISTED
CHUBB CORPORATION
CB
– –
-140,000
Closed -$18.6M
8 9 10 11
12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Polar Capital held 294 positions worth $5.32B, down 3.9% from $5.53B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2016 filing shows 29 new, 89 increased, 98 reduced and 32 closed positions. Its largest new stake was Union Pacific: 603,004 shares worth $48M. The largest sale was Bristol-Myers Squibb, an estimated $36.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2016 buy was Union Pacific: 603,004 shares worth $48M.
  • Polar Capital added most to Gilead Sciences in Q1 2016, an estimated $37M increase.
  • Polar Capital's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $36.5M.
  • Polar Capital fully exited Centene in Q1 2016, selling an estimated $27.3M.
  • Polar Capital's ten largest holdings make up 24% of its $5.32B portfolio in Q1 2016.
  • Polar Capital opened 29 new positions and closed 32 in Q1 2016.
  • Polar Capital's portfolio value fell 3.9% quarter-over-quarter to $5.32B.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.